GB1178984A - Improvements in or relating to Hepatic Medicines - Google Patents
Improvements in or relating to Hepatic MedicinesInfo
- Publication number
- GB1178984A GB1178984A GB28880/67A GB2888067A GB1178984A GB 1178984 A GB1178984 A GB 1178984A GB 28880/67 A GB28880/67 A GB 28880/67A GB 2888067 A GB2888067 A GB 2888067A GB 1178984 A GB1178984 A GB 1178984A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hepatic
- medicines
- june
- relating
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 230000002440 hepatic effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 3
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 abstract 2
- UGQMRVRMYYASKQ-DEGSGYPDSA-N 9-[(2s,3s,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one Chemical compound O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-DEGSGYPDSA-N 0.000 abstract 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 abstract 1
- 229930024421 Adenine Natural products 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- 229960000643 adenine Drugs 0.000 abstract 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 abstract 1
- 235000000639 cyanocobalamin Nutrition 0.000 abstract 1
- 239000011666 cyanocobalamin Substances 0.000 abstract 1
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 abstract 1
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 abstract 1
- 235000004867 hydroxocobalamin Nutrition 0.000 abstract 1
- 239000011704 hydroxocobalamin Substances 0.000 abstract 1
- 229960001103 hydroxocobalamin Drugs 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH913566 | 1966-06-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1178984A true GB1178984A (en) | 1970-01-28 |
Family
ID=4348691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB28880/67A Expired GB1178984A (en) | 1966-06-23 | 1967-06-22 | Improvements in or relating to Hepatic Medicines |
Country Status (4)
Country | Link |
---|---|
BE (1) | BE700365A (zh) |
DE (1) | DE1670234A1 (zh) |
FR (1) | FR7028M (zh) |
GB (1) | GB1178984A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6787527B1 (en) * | 1994-11-10 | 2004-09-07 | Duke University | Methods of preventing and treating HIV infection |
EP1621202A1 (en) * | 2003-05-07 | 2006-02-01 | Eisai Co., Ltd. | Freeze-dried preparation containing methylcobalamin and process for producing the same |
-
1967
- 1967-05-31 FR FR108516A patent/FR7028M/fr not_active Expired
- 1967-06-03 DE DE19671670234 patent/DE1670234A1/de active Pending
- 1967-06-22 BE BE700365D patent/BE700365A/xx unknown
- 1967-06-22 GB GB28880/67A patent/GB1178984A/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6787527B1 (en) * | 1994-11-10 | 2004-09-07 | Duke University | Methods of preventing and treating HIV infection |
EP1621202A1 (en) * | 2003-05-07 | 2006-02-01 | Eisai Co., Ltd. | Freeze-dried preparation containing methylcobalamin and process for producing the same |
EP1621202A4 (en) * | 2003-05-07 | 2007-10-31 | Eisai R&D Man Co Ltd | LYOPHILIZED PREPARATION CONTAINING METHYLCOBALAMINE AND PROCESS FOR PRODUCING THE PREPARATION |
Also Published As
Publication number | Publication date |
---|---|
DE1670234A1 (de) | 1971-01-07 |
FR7028M (zh) | 1969-06-09 |
BE700365A (zh) | 1967-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL36299A0 (en) | 3-octadecyloxypropyl-2'-trimethylammoniumethyl phosphate,its preparation and pharmaceutical compositions containing it | |
GB1310658A (en) | Composition and method for treatment of hepatic disease and mental fatugue | |
IL35078A0 (en) | 2-aminoalkylamino-thieno(3,2-d)-pyrimidines and their salts,their preparation and pharmaceutical compositions containing them | |
GB1388358A (en) | Taste-improving formulations of oral penicillins | |
IL37492A (en) | 6h-oxazolo(or thiazolo)(5,4-d)-azepine derivatives,their salts,preparation thereof and pharmaceutical compositions containing them | |
ES341109A1 (es) | Metodo para la preparacion de nuevas sales basicas de adi- cion de acido ribonucleico. | |
IL37280A (en) | Adenosine-5'-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
GB1178984A (en) | Improvements in or relating to Hepatic Medicines | |
GB1365176A (en) | Benzodiazepine derivatives | |
IL35490A (en) | 6-amidino-penicillanic acid derivatives,their preparation and pharmaceutical compositions containing them | |
IL36201A (en) | 2-chloroethane-(thiono)-phosphonic acid amido compounds,their preparation and their use for the regulation of plant growth | |
ZA706229B (en) | "2-chloroethane-(thiono)-phosphonic acid derivatives,process for their preparation,and their use for the regulation of plant growth | |
GB1067390A (en) | Improvements in or relating to antiviral compositions and treatments | |
IL34468A0 (en) | Acid addition salts of indenopyridine derivatives,their preparation and pharmaceutical compositions containing them | |
IL37875A (en) | Pyridazinothionophosphoric and phosphonic acid esters,their preparation and their use as insecticides and acaricides | |
ZA706381B (en) | 2,4-dioxo-1, 3-benzoxazinothionophosphonic acid esters,process for their preparation,and their use as insecticides and acaricides | |
IL40623A (en) | 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them | |
GB1157662A (en) | Improvements in or relating to Pharmaceutical Compositions | |
GB1169074A (en) | Improvements in or relating to Hepato-Protective Drugs | |
GB1312129A (en) | Antibiotic and process for preparing same | |
IL37887A (en) | Thionophosphoric and thionophosphonic acid ester derivatives,their preparation and their use as insecticides and acaricides | |
IL36096A0 (en) | 2,6-dimorpholino-pyrimido (5,4-d) pyrimidine derivatives,their preparation and pharmaceutical compositions containing them | |
GB1174951A (en) | Improvements in and relating to Animal Feed Compositions | |
GB908076A (en) | Fibrinolytic compositions suitable for buccal administration | |
GB1194912A (en) | Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin |